Humacyte (NASDAQ:HUMA)

Human-based tissue scaffolds, including a biological vascular graft to provide vascular access to end-stage renal disease patients who need hemodialys...

Start Free Trial

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Humacyte (NASDAQ:HUMA) plus 5230 other startups.

Start Free 7 Day Trial Now

Learn More About Humacyte (NASDAQ:HUMA)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

Competing Startups

More

Our Clients

0-Minnetronix.jpg
1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.jpg
bain.jpg
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
hospira.png
jlabs.jpg
kimberlyclark.png
merck.jpg
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
teleflex.jpg
terumo.png
zimmerbiomet.png